Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture and NGF in Ischemic Stroke Recovery
NCT05652751Unknown
- Sponsor
- Third Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Mar 2022
- Primary completion
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of Nerve growth factor in ischemic stroke (4 arms), sponsored by Third Affiliated Hospital of Zhejiang Chinese Medical University. Primary endpoint: modified Rankin Scale at 4 weeks. Status: unknown.
02
Drugs
Nerve growth factor
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05652751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05652751.